Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term renal-cell carcinoma. Found 18 abstracts

de Jesus-Gonzalez N, Robinson E, Penchev R, von Mehren M, Heinrich MC, Tap W, Wang Q, Demetri G, George S, Humphreys BD. Regorafenib Induces Rapid and Reversible Changes in Plasma Nitric Oxide and Endothelin-1. American Journal of Hypertension. 2012 Oct;25(10):1118-23.   PMCID: PMC 3578478
Patson B, Cohen RB, Olszanski AJ. Pharmacokinetic evaluation of axitinib. Expert Opinion on Drug Metabolism & Toxicology. 2012 Feb;8(2):259-70.   PMCID: not NIH funded
Reyes JM, Canter DJ, Sirohi M, Simhan J, Smaldone MC, Teper E, Kutikov A, Chen DY, Uzzo RG. Delayed proximal ureteric stricture formation after complex partial nephrectomy. BJU international. 2012 Feb;109(4):539-43.
Smaldone MC, Egleston B, Uzzo RG, Kutikov A. Does Partial Nephrectomy Result in a Durable Overall Survival Benefit in the Medicare Population?. J Urol. 2012 Dec;188(6):2089-94.   PMCID: PMC 3815608
Cash TP, Gruber JJ, Hartman TR, Henske EP, Simon MC. Loss of the Birt-Hogg-Dube tumor suppressor results in apoptotic resistance due to aberrant TGF beta-mediated transcription. Oncogene. 2011 Jun;30(22):2534-46.   PMCID: PMC3109270
Hoffman AM, Cairns P. Epigenetics of kidney cancer and bladder cancer. Epigenomics. 2011 Feb;3(1):19-34.   PMCID: NIHMS362391
Scoll BJ, Uzzo RG, Chen DY, Boorjian SA, Kutikov A, Manley BJ, Viterbo R. Robot-assisted Partial Nephrectomy: A Large Single-institutional Experience. Urology. 2010 Jun;75(6):1328-34.   PMCID: PMCID: PMC2879432 [Available on 2011/6/1]
Spratlin JL, Cohen RB, Eadens M, Gore L, Camidge DR, Diab S, Leong S, O'Bryant C, Chow LQ, Serkova NJ, Meropol NJ, Lewis NL, Chiorean EG, Fox F, Youssoufian H, Rowinsky EK, Eckhardt SG. Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G(1) Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2. Journal of Clinical Oncology. 2010 Feb;28(5):780-7.   PMCID: PMC2834394
Touijer K, Jacqmin D, Kavoussi LR, Montorsi F, Patard JJ, Rogers CG, Russo P, Uzzo RG, Van Poppel H. The Expanding Role of Partial Nephrectomy: A Critical Analysis of Indications, Results, and Complications. European Urology. 2010 Feb;57(2):214-22.   PMCID: not NIH funded
Welch SA, Hirte HW, Elit L, Schilder RJ, Wang L, MacAlpine K, Wright JJ, Oza AM. Sorafenib in Combination With Gemcitabine in Recurrent Epithelial Ovarian Cancer A Study of the Princess Margaret Hospital Phase II Consortium. International Journal of Gynecological Cancer. 2010 Jul;20(5):787-93.   PMCID: Not required
Dulaimi E, de Caceres, Uzzo RG, Al-Saleem T, Greenberg RE, Polascik TJ, Babb JS, Grizzle WE, Cairns P. Promoter hypermethylation profile of kidney cancer. Clinical Cancer Research. 2004 Jan;10(12):3972-9.
Henske EP. The genetic basis of kidney cancer: Why is tuberous sclerosis complex often overlooked?. Current Molecular Medicine. 2004 Dec;4(8):825-31.
Al-Saleem T, Wessner LL, Scheithauer BW, Patterson K, Roach ES, Dreyer SJ, Fujikawa K, Bjornsson J, Bernstein J, Henske EP. Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex. Cancer. 1998 Nov 15;83(10):2208-16.
Aldaz CM, Yeung RS, Latif F, Lerman MI, Xiao G, Trono D, Walker CL. Colocalization of the Rat Homolog of the Vonhippel-Lindau (Vhl) Gene and the Plasma-Membrane Ca++ Transporting Atpase-Isoform-2 (Atp2b2) Gene to Rat Chromosome Bands 4q41.3- 42.1. Cytogenetics and Cell Genetics. 1995 Jan;71(3):253-6.
Xiao GH, Jin F, Yeung RS. Germ-Line Tsc2 Mutation in a Dominantly Inherited Cancer Model Defines a Novel Family of Rat Intracisternal-a Particle Elements. Oncogene. 1995 Jul 06;11(1):81-7.
Yeung RS, Xiao GH, Everitt JI, Jin F, Walker CL. Allelic Loss at the Tuberous Sclerosis 2 Locus in Spontaneous Tumors in the Eker Rat. Molecular Carcinogenesis. 1995 Sep;14(1):28-36.
Wang ND, Testa JR, Smith DI. Determination of the Specificity of Aphidicolin-Induced Breakage of the Human-3p14.2 Fragile Site. Genomics. 1993 Aug;17(2):341-7.
Wang ND, Testa JR, Smith DI. Localization of 3 Novel Hybrid Breakpoints and Refinement of 18 Marker Assignments in the Human 3cen-P21.1 Region. Genomics. 1992 Dec;14(4):891-6.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term renal-cell carcinoma

renal-cell carcinoma colorectal-cancer nephron-sparing surgery angiogenesis tumor suppressor gene tumor-suppressor gene cancer radical nephrectomy lung-cancer outcomes bevacizumab chromosomal translocation growth suppressor identification carcinoma oncological outcomes eker rat hereditary dna methylation mapping panel chronic kidney-disease positive surgical margins tumors dna cpg-island methylation antitumor-activity mutations solid tumors deletion vonhippel-lindau disease metastatic hereditary cancer model masses phase-ii raf kinase breast-cancer 7 days contrast-enhanced mri hypertension growth dna rearrangement diastolic blood-pressure laparoscopic partial renal cell angiomyolipoma sites tuberous sclerosis Gemcitabine Partial nephrectomy gene hemangiosarcoma dose-escalation e-cadherin VEGF animal model aberrant promoter susceptibility CA125 signaling pathways heterozygosity short platinum arm hippel-lindau-disease long terminal repeats pathway laparoscopic partial nephrectomy o-6-methylguanine-dna methyltransferase sequence normal contralateral kidney Ovarian cancer akt pathway insertion blood pressure antiangiogenic therapy-endothelin-1-hypertension-nitric oxide gastrointestinal stromal tumors proximal ureteric stricture mouse line u2020 chromosome 9q34 morbidity glioblastoma angiogenesis inhibitor epithelioid angiomyolipoma norvegicus bhd gene tyrosine kinase epigenetic inactivation mortality days on promoter hypermethylation loss of heterozygosity mammalian target common fragile leiomyoma Renal cell carcinoma bladder cancer metaanalysis somatic mutations norway rat therapy genome biomarker yolk-sac susceptibility gene promoter vascular endothelial growth factor suppressor gene partial nephrectomy localization Renal tumours blood-pressure inhibitor sunitinib multiple genes AG-013736 clear-cell genetic-linkage paclitaxel bh3-only protein bim mtor activation iap element expression tsc1 renal cell carcinoma-nephrectomy-survival-risk assessment Sorafenib nephrectomy protein malignant-tumors 3p14 apoptosis BHD-Bim-TGF beta-mTOR refractory solid tumors growth-factor-beta cm human neoplasia tuberous endothelial growth-factor Antiangiogenic small region hogg-dube-syndrome 10-year follow-up liver metastases predisposition 4 cm Nephron-sparing surgery trends hippel-lindau disease 3-kinase trial hybridization VEGFR axitinib
Last updated on Sunday, July 12, 2020